| Identification | Back Directory | [Name]
FMOC-T-BUTYL-L-ALANINE | [CAS]
139551-74-9 | [Synonyms]
FMOC-LEU(ME)-OH
FMOC-ALA(TBU)-OH
FMOC-L-NPTGLY-OH
Fmoc-L-tBuAla-OH
Fmoc-β-tBu-Ala-OH
FMoc-b-tBu-Ala-OH
Fmoc-b-tBu-Ala-OH·HCl
Fmoc-neopentylglycine
FMOC-(NEOPENTYL)GLY-OH
FMOC-T-BUTYL-L-ALANINE
FMOC-L-NEOPENTYLGLYCINE
Fmoc-4-methyl-L-leucine
Fmoc-b-t-butyl-L-alanine
N-Fmoc-4-methyl-L-leucine
FMOC-L-BETA-T-BUTYLALANINE
Fmoc-beta-t-butyl-L-alanine
FMOC-T-BUTYL-L-ALANINE USP/EP/BP
(9H-Fluoren-9-yl)MethOxy]Carbonyl tBuAla-OH
N-(9-FLUORENYLMETHYLOXYCARBONYL)-NEOPENTYLGLYCINE
N-α-(9-Fluorenylmethoxycarbonyl)-β-(t-butyl)-L-alanine
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-methyl-L-leucine
L-Leucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-methyl-
N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-L-NEOPENTYLGLYCINE
N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-GAMMA-METHYL-L-LEUCINE
N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-BETA-T-BUTYL-L-ALANINE
N-ALPHA-(9-FLUOROENYLMETHOXYCARBONYL)-GAMMA-METHYL-L-LEUCINE
N-ALPHA-(9-FLUOROENYLMETHOXYCARBONYL)-BETA-T-BUTYL-L-ALANINE
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4,4-dimethylpentanoicaci
(S)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)(tert-butyl)aMino)propanoic acid
(S)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-4,4-diMethylpentanoic acid
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4,4-dimethylpentanoic acid | [Molecular Formula]
C22H25NO4 | [MDL Number]
MFCD00671389 | [MOL File]
139551-74-9.mol | [Molecular Weight]
367.44 |
| Chemical Properties | Back Directory | [Boiling point ]
562.7±33.0 °C(Predicted) | [density ]
1.189±0.06 g/cm3 (20 ºC 760 Torr) | [storage temp. ]
Sealed in dry,2-8°C | [form ]
solid | [pka]
3.92±0.23(Predicted) | [InChI]
InChI=1S/C22H25NO4/c1-22(2,3)12-19(20(24)25)23-21(26)27-13-18-16-10-6-4-8-14(16)15-9-5-7-11-17(15)18/h4-11,18-19H,12-13H2,1-3H3,(H,23,26)(H,24,25)/t19-/m0/s1 | [InChIKey]
RPLVCXKSSXJFDS-IBGZPJMESA-N | [SMILES]
C(O)(=O)[C@H](CC(C)(C)C)NC(OCC1C2=C(C=CC=C2)C2=C1C=CC=C2)=O |
| Hazard Information | Back Directory | [Uses]
Fmoc-t-butyl-L-alanine is used in the synthesis arylaminoethyl amides as noncovalent inhibitors of cathepsin S. It is also an intermediate used to prepare oxamyl dipeptide caspase inhibitors developed for the treatment of stroke. |
|
|